Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Resistant Hypertension
NCT00430794Phase 2Terminated
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in hypertension (HTN), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Mar 2007; status: terminated.
02
Drugs
spironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00430794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430794.